These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 12018463)

  • 41. Protracted protection to Plasmodium berghei malaria is linked to functionally and phenotypically heterogeneous liver memory CD8+ T cells.
    Berenzon D; Schwenk RJ; Letellier L; Guebre-Xabier M; Williams J; Krzych U
    J Immunol; 2003 Aug; 171(4):2024-34. PubMed ID: 12902507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD8
    Mellouk A; Bobé P
    FASEB J; 2019 Mar; 33(3):3225-3236. PubMed ID: 30383448
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor-primed, in vitro-activated CD4+ effector T cells establish long-term memory without exogenous cytokine support or ongoing antigen exposure.
    Wang LX; Plautz GE
    J Immunol; 2010 May; 184(10):5612-8. PubMed ID: 20382887
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Selective CD28 Antagonist Blunts Memory Immune Responses and Promotes Long-Term Control of Skin Inflammation in Nonhuman Primates.
    Poirier N; Chevalier M; Mary C; Hervouet J; Minault D; Baker P; Ville S; Le Bas-Bernardet S; Dilek N; Belarif L; Cassagnau E; Scobie L; Blancho G; Vanhove B
    J Immunol; 2016 Jan; 196(1):274-83. PubMed ID: 26597009
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development, trafficking, and function of memory T-cell subsets.
    Lefrançois L
    Immunol Rev; 2006 Jun; 211():93-103. PubMed ID: 16824120
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulatory dendritic cells program generation of interleukin-4-producing alternative memory CD4 T cells with suppressive activity.
    Xu X; Guo Z; Jiang X; Yao Y; Gao Q; Ding Y; Cao X
    Blood; 2011 Jan; 117(4):1218-27. PubMed ID: 21051555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells.
    Yang S; Gattinoni L; Liu F; Ji Y; Yu Z; Restifo NP; Rosenberg SA; Morgan RA
    Cancer Immunol Immunother; 2011 May; 60(5):739-49. PubMed ID: 21305379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cutting edge: L-selectin (CD62L) expression distinguishes small resting memory CD4+ T cells that preferentially respond to recall antigen.
    Hengel RL; Thaker V; Pavlick MV; Metcalf JA; Dennis G; Yang J; Lempicki RA; Sereti I; Lane HC
    J Immunol; 2003 Jan; 170(1):28-32. PubMed ID: 12496379
    [TBL] [Abstract][Full Text] [Related]  

  • 49. L-selectin-negative CCR7- effector and memory CD8+ T cells enter reactive lymph nodes and kill dendritic cells.
    Guarda G; Hons M; Soriano SF; Huang AY; Polley R; Martín-Fontecha A; Stein JV; Germain RN; Lanzavecchia A; Sallusto F
    Nat Immunol; 2007 Jul; 8(7):743-52. PubMed ID: 17529983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes.
    Chin CS; Miller CH; Graham L; Parviz M; Zacur S; Patel B; Duong A; Bear HD
    Int Immunol; 2004 Sep; 16(9):1283-94. PubMed ID: 15262898
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of CC-chemokine receptor 7 expression on murine T cells in lymphoid tissues.
    Bjorkdahl O; Barber KA; Brett SJ; Daly MG; Plumpton C; Elshourbagy NA; Tite JP; Thomsen LL
    Immunology; 2003 Oct; 110(2):170-9. PubMed ID: 14511230
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decisions on the road to memory.
    Amsen D; Backer RA; Helbig C
    Adv Exp Med Biol; 2013; 785():107-20. PubMed ID: 23456843
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Constitutive activation of Wnt signaling favors generation of memory CD8 T cells.
    Zhao DM; Yu S; Zhou X; Haring JS; Held W; Badovinac VP; Harty JT; Xue HH
    J Immunol; 2010 Feb; 184(3):1191-9. PubMed ID: 20026746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression.
    Hiura T; Kagamu H; Miura S; Ishida A; Tanaka H; Tanaka J; Gejyo F; Yoshizawa H
    J Immunol; 2005 Oct; 175(8):5058-66. PubMed ID: 16210609
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Central memory CD8+ T cells become CD69+ tissue-residents during viral skin infection independent of CD62L-mediated lymph node surveillance.
    Osborn JF; Hobbs SJ; Mooster JL; Khan TN; Kilgore AM; Harbour JC; Nolz JC
    PLoS Pathog; 2019 Mar; 15(3):e1007633. PubMed ID: 30875408
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cutting edge: effector memory CD8+ T cells play a prominent role in recall responses to secondary viral infection in the lung.
    Roberts AD; Woodland DL
    J Immunol; 2004 Jun; 172(11):6533-7. PubMed ID: 15153466
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suppression of IgG memory responses by T cells activated with the type 2 antigen polyvinylpyrrolidone (PVP).
    Van Buskirk AM; Braley-Mullen H
    Cell Immunol; 1987 Jun; 107(1):121-9. PubMed ID: 2953441
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effector to memory transition of CD4 T cells.
    McKinstry KK; Strutt TM; Swain SL
    Immunol Res; 2008; 40(2):114-27. PubMed ID: 18213525
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early signals during CD8 T cell priming regulate the generation of central memory cells.
    Obar JJ; Lefrançois L
    J Immunol; 2010 Jul; 185(1):263-72. PubMed ID: 20519649
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functionally distinct CD8+ memory T cell subsets in persistent EBV infection are differentiated by migratory receptor expression.
    Tussey L; Speller S; Gallimore A; Vessey R
    Eur J Immunol; 2000 Jul; 30(7):1823-9. PubMed ID: 10940871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.